The Canadianregulations, which passed in mid-March, were revisions ofregulations that had been drafted in 1980.
Risankizumab Efficacious in Patients with Prior Plaque Psoriasis Biologic Use
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Roflumilast Safe and Efficient for Patients with Chronic Plaque Psoriasis
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
New Guidelines to Prevent Food Allergies in Pediatric Atopic Dermatitis Patients
Phase 3 Data for Bimekizumab Shows Well Maintained Response